Clinical Trials on Platinum Sensitive Relapsed Ovarian Cancer
Total 9276 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eli Lilly and CompanyCompletedPemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Astellas Pharma Korea, Inc.Not yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
Jianbin BiNot yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
BayerRecruitingMetastatic Hormone-sensitive Prostate Cancer (mHSPC)Japan
-
Janssen-Cilag Ltd.RecruitingMetastatic Hormone-sensitive Prostate CancerFrance, Germany, Spain, Greece, United Kingdom, Austria
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
UNICANCERRecruitingOligometastatic Hormone Sensitive Prostate CancerFrance, Martinique
-
BayerCompletedMetastatic Castration-sensitive Prostate CancerCanada
-
Hoffmann-La RocheCompletedColorectal Cancer, Ovarian CancerBelgium, Spain, United Kingdom
-
Paul ViscuseNot yet recruitingMetastatic Prostate Cancer | Castrate Sensitive Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Fundacion Clinic per a la Recerca BiomedicaNot yet recruiting
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Malignant Ovarian Clear Cell Tumor | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian... and other conditions
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
Medical University of ViennaCompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Belgium, Czechia, Denmark, Germany, Ireland, Netherlands, United Kingdom
-
Vejle HospitalAbbottCompletedRecurrent, Epithelial Ovarian CancerDenmark
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial CancerUnited States
-
Inge Marie SvaneRecruitingPeritoneal Cancer | Metastatic Ovarian Cancer | Metastatic Fallopian Tube CancerDenmark
-
NRG OncologyNational Cancer Institute (NCI)RecruitingOvarian CarcinomaUnited States, Korea, Republic of
-
Paul Speiser, Prof.MD,CompletedCarcinoma in Situ | Ovarian Cancer | Ovarian Epithelial CancerAustria, Czechia, Germany, Ireland
-
Gradalis, Inc.CompletedStage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Mario Negri Institute for Pharmacological ResearchHoffmann-La Roche; PharmaMarCompletedOvarian Epithelial Cancer RecurrentItaly
-
Beth Israel Deaconess Medical CenterMassachusetts General Hospital; Sanofi; University of Southern California; VA Boston... and other collaboratorsCompletedAdvanced Pancreatic, Colon, Lung, Gastric and Ovarian CancerUnited States
-
Institut Paoli-CalmettesUNICANCER - Le Groupe génétique et cancer (GGC)RecruitingBreast Cancers | Ovarian CancersFrance
-
GlaxoSmithKlineCompletedNeoplasms, OvarianUnited States
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.RecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerChina
-
ImmunoGen, Inc.Gynecologic Oncology Group; European Network of Gynaecological Oncological...Active, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerUnited States, Canada, Germany, China, France, Korea, Republic of, Belgium, United Kingdom, Serbia, Spain, Australia, Israel, Italy, Taiwan, Czechia, Bulgaria, Netherlands, Portugal, Poland, Russian Federation, Ukraine
-
Duke UniversityCompletedFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer, EpithelialUnited States
-
Bital Savir-BaruchBlue Earth DiagnosticsUnknownCervical Cancer | Ovarian Epithelial Cancer | Endometrial CancerUnited States
-
Catholic University of the Sacred HeartCompletedStage IIIC Ovarian CancerItaly
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOvarian CarcinomaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Stage IV Primary Peritoneal Cavity Cancer | Stage IIIA Ovarian Epithelial Cancer | Stage IIIB Ovarian Epithelial Cancer | Stage IIIC Ovarian Epithelial Cancer | Stage IIIA Primary... and other conditionsUnited States
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of QueenslandCompletedOvarian Cancer Stage IV | Ovarian Cancer Stage IIIAustralia
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Medical Research Council; Southwest Oncology...CompletedPrimary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Ovarian Epithelial CancerUnited States
-
Nordic Society of Gynaecological Oncology - Clinical...CompletedOvarian Epithelial Cancer RecurrentDenmark, Finland, Norway
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian Cancer | Stage IIIB Primary Peritoneal Cancer | Stage IIIC Fallopian Tube Cancer | Stage IIIC Ovarian Cancer | Stage IIIC Primary Peritoneal Cancer and other conditionsUnited States
-
Ain Shams Maternity HospitalCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Cervical Cancer | Recurrent Vaginal Cancer | Recurrent Vulvar Cancer | Stage III Vaginal Cancer | Stage IVA Cervical Cancer | Stage IVA Vaginal Cancer | Stage IVB Cervical Cancer | Stage IVB Vaginal Cancer | Stage IIIA Ovarian... and other conditionsUnited States
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China